Dr. Balandya is a physician-scientist with medical, doctoral and post-doctoral training. He obtained his MD at the University of Dar-es-salaam in Tanzania in 2005. Since 2007, he has been faculty at the School of Medicine, Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania. He was awarded the prestigious NIH AITRP-Fogarty Fellowship in 2008 to purse Doctor of Philosophy (PhD) studies at Dartmouth College in the United States and graduated in 2012. He subsequently joined the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School as a post-doctoral research fellow between 2012-2014. With a Fogarty Global Health Fellowship supported by the National Heart, Lung and Blood Institute (NHLBI), Fogarty and the University of California Global Health Institute (UCGHI) he returned to MUHAS and focused his research on the role played by T and B lymphocytes in the immunity of children with sickle cell anemia in Tanzania.
Dr. Balandya has a solid background in immunology, vaccinology and advanced biomedical physiology, and has contributed in the fields of mucosal immunology, primary HIV transmission, HIV vaccine development and immunity in sickle cell anemia.
He is currently the Tanzanian PI for SPARCO and Acting Director, Directorate of Postgraduate studies at MUHAS.